Back
WisdomTree Global ex-US Quality Growth Fund Vs. Insmed, Inc. Industry Stock Comparison
Sell
50
DNL
WisdomTree Global ex-US Quality Growth Fund
Last Price:
$41.12
Seasonality Move:
1.75%
Sell
40
INSM
Insmed, Inc.
Last Price:
$174.52
Seasonality Move:
7.61%
Sell
50
WisdomTree Global ex-US Quality Growth Fund (DNL)
is a Sell
Is WisdomTree Global ex-US Quality Growth Fund a Buy, Sell or Hold?
-
The current WisdomTree Global ex-US Quality Growth Fund [DNL] share price is $41.12. The Score for DNL is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
DNL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
40
Insmed, Inc. (INSM)
is a Sell
Is Insmed, Inc. a Buy, Sell or Hold?
-
The current Insmed, Inc. [INSM] share price is $174.84. The Score for INSM is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
-
INSM is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
DNL Stock Price Chart
What is WisdomTree Global ex-US Quality Growth Fund's stock price today?
-
The WisdomTree Global ex-US Quality Growth Fund share price today is $41.12Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DNL is experiencing slight selling pressure.
INSM Stock Price Chart
What is Insmed, Inc.'s stock price today?
-
The Insmed, Inc. share price today is $174.84Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and INSM is experiencing slight buying pressure.
DNL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.1 | Buy |
| Relative Strength Index (14 RSI): | 54.21 | Buy |
| Chaikin Money Flow: | -1050 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
INSM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.64 | Sell |
| Relative Strength Index (14 RSI): | 37.6 | Sell |
| Chaikin Money Flow: | 7900670 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
DNL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 41.06 | Buy |
| 20-day SMA: | 40.74 | Buy |
| 50-day SMA: | 40.8 | Buy |
| 200-day SMA: | 39.15 | Buy |
| 8-day EMA: | 40.94 | Buy |
| 20-day EMA: | 40.85 | Buy |
| 50-day EMA: | 40.7 | Buy |
| 200-day EMA: | 39.62 | Buy |
INSM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 189.94 | Sell |
| 20-day SMA: | 198.55 | Sell |
| 50-day SMA: | 186.85 | Sell |
| 200-day SMA: | 121.67 | Buy |
| 8-day EMA: | 187.6 | Sell |
| 20-day EMA: | 192.95 | Sell |
| 50-day EMA: | 184.53 | Sell |
| 200-day EMA: | 136 | Buy |
WisdomTree Global ex-US Quality Growth Fund Earnings Growth & DNL Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Insmed, Inc. Earnings Growth & INSM Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.47 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.77 per share, and an increase next year of $2.60 per share.
WisdomTree Global ex-US Quality Growth Fund Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Insmed, Inc. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||